DaVita reports Q3 adjusted EPS $2.85, consensus $2.02

Reports Q3 revenue $3.1B, consensus $3.02B. “We delivered another strong quarter,” said Javier Rodriguez, CEO of DaVita Inc. “We began the year by making progress earlier than expected across many of our key operating priorities, and that momentum has continued into the third quarter. We have balanced a strong focus on near-term operating discipline, while continuing to invest in future growth. At the same time, we’re creating a differentiated experience for our teammates, and delivering the highest standard of care for our patients.”